DYN vs ORCL · $1.19B cap vs P/E 31, rev $67.36B
Dyne Therapeutics Inc (DYN) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
DYN does not have a complete income-statement cache yet.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
DYN currently screens at market cap $1.19B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the DYN and ORCL stock pages for the full models.
Not investment advice.